Home Cart Sign in  
Chemical Structure| 1693731-40-6 Chemical Structure| 1693731-40-6

Structure of CCT251236
CAS No.: 1693731-40-6

Chemical Structure| 1693731-40-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CCT251236 is a HSF1 pathway inhibitor with IC50 value of 19nM for inhibition of HSF1-mediated HSP72 induction, and a tight-binding ligand of pirin with Kd value of 44nM. It displays efficacy in a human ovarian carcinoma xenograft model.

Synonyms: CCT251236

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CCT251236

CAS No. :1693731-40-6
Formula : C32H32N4O5
M.W : 552.62
SMILES Code : O=C(C1=CC=C2N=C(OCCN3CCCC3)C=CC2=C1)NC4=CC(NC(C5=CC=C6OCCOC6=C5)=O)=CC=C4C
Synonyms :
CCT251236
MDL No. :MFCD30738050
InChI Key :KLHOCHQJHXNKAS-UHFFFAOYSA-N
Pubchem ID :117996749

Safety of CCT251236

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Related Pathways of CCT251236

pyroptosis

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.05mL

1.81mL

0.90mL

18.10mL

3.62mL

1.81mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories